Alzheimer's skin patch on Greek market
A new treatment, in the form of a skin patch, will be used by patients suffering from Alzheimer's disease and Parkinson's dementia, and is expected to be on the Greek market in October. The patch will be used to convey the drug rivastigmine through patients' skin, eliminating the need for the consumption of pills orally on a daily basis. The announcement was made during the 5th conference on Alzheimer's Disease and Related Disorders, held in Thessaloniki.
Λεπτομέρειες στη συνδρομητική σελίδα του ΑΠΕ-ΜΠΕ | Αίτηση Συνδρομητή